IceCure Medical Ltd
ICCM
$2.52
-$0.30-10.50%
NASDAQ
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | 46.17% | -48.07% | -2.42% | -30.28% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 46.17% | -48.07% | -2.42% | -30.28% | |
| Cost of Revenue | 48.25% | -18.09% | 6.96% | -33.24% | |
| Gross Profit | 43.88% | -75.28% | -18.96% | -26.71% | |
| SG&A Expenses | -22.39% | -16.94% | 12.35% | 54.55% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 1.76% | -7.76% | -0.25% | 15.63% | |
| Operating Income | 6.83% | -4.86% | -0.19% | -32.50% | |
| Income Before Tax | 5.20% | -9.19% | 0.58% | -49.55% | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | 5.20% | -9.19% | 0.58% | -49.55% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | 5.20% | -9.19% | 0.58% | -49.55% | |
| EBIT | 6.83% | -4.86% | -0.19% | -32.50% | |
| EBITDA | 6.71% | -5.63% | -0.08% | -33.34% | |
| EPS Basic | 26.88% | 8.90% | 19.43% | -21.95% | |
| Normalized Basic EPS | 27.00% | 8.91% | -- | -21.95% | |
| EPS Diluted | 26.88% | 8.90% | 19.43% | -21.95% | |
| Normalized Diluted EPS | 27.00% | 8.91% | -- | -21.95% | |
| Average Basic Shares Outstanding | 29.66% | 19.82% | 23.33% | 22.62% | |
| Average Diluted Shares Outstanding | 29.66% | 19.82% | 23.33% | 22.62% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |